Finzati - Logo
PBAXU logo

Phoenix Biotech Acquisition Corp.

PBAXU • Shell Companies
$0.01
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$36.54M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.3Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.01
Change0.00%
Market Cap$36.54M
Beta0.04
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.13
Current Ratio0.30
Quick Ratio0.30
Volume7.00
Avg Volume92.00

Investment DNA

How strong this company looks for long-term investors

41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Weak liquidity · 0.3Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 10/6/2021
Industry: Shell Companies
P/B i: -0.05
Debt / Equity i: -0.13
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.13
Current Ratio: 0.30
Quick Ratio: 0.30
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Francois Eric
Transaction: 03/04/2026
BUY
Change
+1,823,278
Price
$0.06
Filing
04/21/2026
Type
BUY
Francois Eric
Transaction: 02/13/2026
OTHER
Change
0
Price
Not reported
Filing
04/21/2026
Type
OTHER
KUCHARCHUK ANDREW ALBERT
Transaction: 01/07/2026
BUY
Change
+1,162,099
Price
$0.06
Filing
01/09/2026
Type
BUY